May 18- Buyout firm Onex Corp has revived an auction for Carestream Health that could value it at more than $3 billion, including debt, and is exploring a break up of the U.S. medical imaging company, people familiar with the matter said. Carestream is now working with Goldman Sachs Group Inc to find a buyer for its film and digital medical imaging business, while...
May 18- Medtronic Inc, the world's largest standalone medical device maker, wants to slice deeper into the minimally invasive surgical products market and is buying its way in. Separately, Medtronic also bought Smith& Nephew Plc's gynecology unit for $350 million to gain access to a surgical platform that helps remove abnormal uterine tissue such as polyps and...
A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.
*Apple shares sink after Carl Icahn comments. "This really personifies how important central bank policy is on the market," said Jack Ablin, chief investment officer at BMO Private Bank. Jude Medical soared 26.3 percent to $78.22 after Abbott Laboratories said it agreed to buy the medical device maker for $25 billion.
Jude Medical soars after $25 bln offer from Abbott. Facebook jumped as much as 10.9 percent to a record of $120.79, a day after the company reported a 50 percent rise in revenue. Jude Medical soared 27.2 percent to $78.77 after Abbott Laboratories said it agreed to buy the medical device maker for $25 billion.
Jude Medical soars after $25 bln offer from Abbott. Jude Medical soared 25.1 percent to $77.47 after Abbott Laboratories said it agreed to buy the medical device maker for $25 billion. DreamWorks Animation was up 24.2 percent at $39.99, after Comcast said it will buy the company for $3.8 billion.
The company also raised its 2016 adjusted profit forecast to $4.01 to $4.11 per share from its previous estimate of $3.95 to $4.05 per share. For the first quarter ended April 2, earnings attributable to the company fell to $95 million, or 33 cents per share, from $262 million, or 91 cents per share, a year earlier. Excluding after-tax charges of 57 cents per share, the...
For the first quarter ended April 2, earnings attributable to the company fell to $95 million, or 33 cents per share, from $262 million, or 91 cents per share a year earlier. In the quarter, the company recognized net after-tax charges of $164 million, or $0.57 per share, primarily related to acquisition-related costs and restructuring activities.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
But, instead of reporting the events to the U.S. Food and Drug Administration, within 30 days of discovering them, as required by law, Medtronic hid them, the Star Tribune said. Medtronic officials told the Star Tribune that the database of adverse events was misfiled internally and was reported to the FDA after it was rediscovered more than five years later.
April 6- Medtronic Plc's wireless pacemaker was approved by the U.S. Food and Drug Administration on Wednesday, making it the first pacemaker in the United States that does not need wired leads to correct slow heart rates. The FDA evaluated data from a clinical trial involving 719 and found that 98 percent of patients had a stable heart pacing for at least six...
April 6- Medtronic Plc's wireless pacemaker was approved in the United states on Wednesday, making it the first pacemaker that does not need wired leads to correct slow heart rate. The device named Micra pacemaker is delivered to the heart chambers through a patient's arteries through a catheter, unlike traditional pacemakers that are implanted through an...
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
Bill Ackman should have listened!
Ben Young, Sworkit founder & CEO, explains how a new fitness app allows users to customize personalized workout videos.
Loncar Investments CEO, Brad Loncar says immunotherapy is the most innovative, high-growth area in the biotech space, while describing the company’s ETF.
Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.
Jonathan Adiri, CEO of Healthy.io, discusses how smart phones, wearables and tech will impact health care.
U.S. health inspectors found problems at Theranos' northern California laboratory.
In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'